Abstract
BackgroundCorticosteroid (CS) is effective for controlling inflammatory reactions in SLE, but may have been known to increase risk of avascular necrosis (AVN) in patients with Systemic lupus erythematosus (SLE). This...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have